Paraoxonases Activities and Polymorphisms in Elderly and Old-Age Diseases: An Overview

Carregando...
Imagem de Miniatura
Citações na Scopus
36
Tipo de produção
article
Data de publicação
2019
Editora
MDPI
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
ANTIOXIDANTS, v.8, n.5, article ID 118, 24p, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Aging is defined as the accumulation of progressive organ dysfunction. There is much evidence linking the involvement of oxidative stress in the pathogenesis of aging. With increasing age, susceptibility to the development of diseases related to lipid peroxidation and tissue injury increases, due to chronic inflammatory processes, and production of reactive oxygen species (ROS) and free radicals. The paraoxonase (PON) gene family is composed of three members (PON1, PON2, PON3) that share considerable structural homology and are located adjacently on chromosome 7 in humans. The most studied member product is PON1, a protein associated with high-density lipoprotein with paraoxonase/esterase activity. Nevertheless, all the three proteins prevent oxidative stress. The major aim of this review is to highlight the importance of the role of PON enzymes in the aging process, and in the development of the main diseases present in the elderly: cardiovascular disease, diabetes mellitus, neurodegenerative diseases, and cancer.
Palavras-chave
aging, paraoxonase, PON, lipids, lipid peroxidation, heart disease, atherosclerosis, diabetes, cancer, neurodegenerative diseases
Referências
  1. Ademowo OS, 2017, BIOGERONTOLOGY, V18, P859, DOI 10.1007/s10522-017-9710-z
  2. ADKINS S, 1993, AM J HUM GENET, V52, P598
  3. Ahmed Nagwa S, 2015, Asian Pac J Cancer Prev, V16, P803
  4. Akbas HS, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-92
  5. Alaminos-Castillo MA, 2019, INT J CLIN PRACT, V73, DOI 10.1111/ijcp.13315
  6. Alique M, 2015, FOOD NUTR RES, V59, DOI 10.3402/fnr.v59.29240
  7. Altenhofer S, 2010, J BIOL CHEM, V285, P24398, DOI 10.1074/jbc.M110.118604
  8. Amitai G, 2006, FEBS J, V273, P1906, DOI 10.1111/j.1742-4658.2006.05198.x
  9. AnandBabu K, 2016, EXP EYE RES, V152, P100, DOI 10.1016/j.exer.2016.09.009
  10. Ansari SA, 2017, BLOOD ADV, V1, P2399, DOI 10.1182/bloodadvances.2017010132
  11. Aragones G, 2012, J LIPID RES, V53, P168, DOI 10.1194/jlr.P018457
  12. Arenas M, 2018, CRIT REV ONCOL HEMAT, V127, P6, DOI 10.1016/j.critrevonc.2018.04.005
  13. Arimon M, 2015, NEUROBIOL DIS, V84, P109, DOI 10.1016/j.nbd.2015.06.013
  14. Aviram M, 2004, FREE RADICAL BIO MED, V37, P1304, DOI 10.1016/j.freeradbiomed.2004.06.030
  15. Aviram M, 1998, J CLIN INVEST, V101, P1581, DOI 10.1172/JCI1649
  16. Bacchetti T, 2019, SEMIN CANCER BIOL, V56, P72, DOI 10.1016/j.semcancer.2017.11.013
  17. Baharudin R, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00047
  18. Balder JW, 2013, CURR OPIN LIPIDOL, V24, P500, DOI 10.1097/MOL.0000000000000018
  19. Barim AO, 2009, CLIN BIOCHEM, V42, P1076, DOI 10.1016/j.clinbiochem.2009.02.020
  20. Bednarska-Makaruk M, 2017, BIOGERONTOLOGY, V18, P561, DOI 10.1007/s10522-017-9701-0
  21. Bednarska-Makaruk M, 2015, ARCH GERONTOL GERIAT, V60, P153, DOI 10.1016/j.archger.2014.10.010
  22. Berrougui H, 2009, REJUV RES, V12, P117, DOI 10.1089/rej.2008.0840
  23. Bhattacharyya T, 2008, JAMA-J AM MED ASSOC, V299, P1265, DOI 10.1001/jama.299.11.1265
  24. Borowczyk K, 2012, J ALZHEIMERS DIS, V30, P225, DOI 10.3233/JAD-2012-111940
  25. Bozan N, 2018, J CHIN MED ASSOC, V81, P811, DOI 10.1016/j.jcma.2018.02.004
  26. Breitenstein A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053106
  27. Bullo M, 2011, CURR TOP MED CHEM, V11, P1797, DOI 10.2174/156802611796235062
  28. BYDLOWSKI SP, 1987, AM J PHYSIOL, V252, pH14
  29. BYDLOWSKI SP, 1987, INT J VITAM NUTR RES, V57, P217
  30. Cakatay U, 2008, CLIN EXP MED, V8, P51, DOI 10.1007/s10238-008-0156-0
  31. Caliebe A, 2010, AGEING RES REV, V9, P238, DOI 10.1016/j.arr.2010.03.003
  32. Camare C, 2017, REDOX BIOL, V12, P18, DOI 10.1016/j.redox.2017.01.007
  33. Camuzcuoglu H, 2009, J WOMENS HEALTH, V18, P1435, DOI 10.1089/jwh.2008.1213
  34. Castellazzi M, 2016, INT J BIOCHEM CELL B, V81, P356, DOI 10.1016/j.biocel.2016.06.008
  35. Cazzaniga A, 2019, FASEB J, V33, P5957, DOI 10.1096/fj.201801586RR
  36. Cherki M, 2005, NUTR METAB CARDIOVAS, V15, P352, DOI 10.1016/j.numecd.2004.08.005
  37. Cherki M, 2007, EXP GERONTOL, V42, P815, DOI 10.1016/j.exger.2007.04.006
  38. Chi Dong-Sheng, 2006, Zhonghua Liu Xing Bing Xue Za Zhi, V27, P808
  39. Childs BG, 2016, SCIENCE, V354, P472, DOI 10.1126/science.aaf6659
  40. Christiansen L, 2004, EUR J HUM GENET, V12, P843, DOI 10.1038/sj.ejhg.5201235
  41. Correale J, 2017, BRAIN, V140, P527, DOI 10.1093/brain/aww258
  42. Costa LG, 2003, BIOMARKERS, V8, P1, DOI 10.1080/13547500210148315
  43. Costa LG, 2014, NEUROTOXICOLOGY, V43, P3, DOI 10.1016/j.neuro.2013.08.011
  44. Cronin S, 2007, J NEUROL NEUROSUR PS, V78, P984, DOI 10.1136/jnnp.2006.112581
  45. da Cunha J, 2013, CLIN CHEM LAB MED, V51, P371, DOI 10.1515/cclm-2012-0225
  46. Davalli P, 2016, OXID MED CELL LONGEV, DOI 10.1155/2016/3565127
  47. Deakin S, 2005, ATHEROSCLEROSIS, V179, P17, DOI 10.1016/j.atherosclerosis.2004.08.039
  48. Deng Z, 2018, Herz, DOI 10.1007/s00059-018-4737-8
  49. Devarajan A, 2011, ANTIOXID REDOX SIGN, V14, P341, DOI 10.1089/ars.2010.3430
  50. Diffenderfer MR, 2014, CURR OPIN LIPIDOL, V25, P221, DOI 10.1097/MOL.0000000000000067
  51. do Amaral VF, 2005, EUR J OBSTET GYN R B, V119, P72, DOI 10.1016/j.ejogrb.2004.07.020
  52. Draganov DI, 2000, J BIOL CHEM, V275, P33435, DOI 10.1074/jbc.M004543200
  53. Draganov DI, 2005, J LIPID RES, V46, P1239, DOI 10.1194/jlr.M400511-JLR200
  54. Dye L, 2017, P NUTR SOC, V76, P443, DOI 10.1017/S0029665117002014
  55. Ebert J, 2018, BLOOD, V131, P2161, DOI 10.1182/blood-2017-09-807040
  56. Eghbali M., 2019, J MOL CELL CARDIOL, P154
  57. El Assar M, 2013, FREE RADICAL BIO MED, V65, P380, DOI 10.1016/j.freeradbiomed.2013.07.003
  58. Eren E, 2014, J CLIN DIAGN RES, V8, pCE01, DOI 10.7860/JCDR/2014/7827.4773
  59. Estrada-Luna D, 2018, MOLECULES, V23, DOI 10.3390/molecules23112730
  60. Faria JR, 2006, BRAZ J MED BIOL RES, V39, P455, DOI 10.1590/S0100-879X2006000400005
  61. Feleciano DR, 2016, MOL CELL ONCOL, V3, DOI 10.1080/23723556.2015.1091060
  62. Fernandes LR, 2017, J PROTEOMICS, V151, P12, DOI 10.1016/j.jprot.2016.06.011
  63. Ferreira AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057937
  64. Maselli LMF, 2014, DIS MARKERS, P1, DOI 10.1155/2014/480201
  65. Finkelstein JD, 2000, SEMIN THROMB HEMOST, V26, P219, DOI 10.1055/s-2000-8466
  66. Fuhrman B, 2005, ATHEROSCLEROSIS, V180, P55, DOI 10.1016/j.atherosclerosis.2004.12.009
  67. Fulop P, 2016, CHEM-BIOL INTERACT, V259, P388, DOI 10.1016/j.cbi.2016.04.003
  68. Furlong CE, 2000, NEUROTOXICOLOGY, V21, P581
  69. Furlong CE, 2016, CHEM-BIOL INTERACT, V259, P51, DOI 10.1016/j.cbi.2016.05.036
  70. Garrick JM, 2016, CHEM-BIOL INTERACT, V259, P168, DOI 10.1016/j.cbi.2016.04.001
  71. Genoud V, 2018, J THROMB THROMBOLYS, V45, P66, DOI 10.1007/s11239-017-1574-1
  72. Giordano G, 2013, FREE RADICAL BIO MED, V58, P98, DOI 10.1016/j.freeradbiomed.2013.01.019
  73. Golzari Mohammad Hassan, 2019, Clin Nutr Res, V8, P17, DOI 10.7762/cnr.2019.8.1.17
  74. Gomathi P, 2018, GENE, V650, P55, DOI 10.1016/j.gene.2018.01.094
  75. Goswami B, 2009, CLIN CHIM ACTA, V410, P1, DOI 10.1016/j.cca.2009.09.025
  76. Goulet EDB, 2009, EXP GERONTOL, V44, P740, DOI 10.1016/j.exger.2009.08.008
  77. Gugliucci A, 2015, CLIN CHIM ACTA, V439, P5, DOI 10.1016/j.cca.2014.09.016
  78. Hafez MM, 2014, OXID MED CELL LONGEV, DOI 10.1155/2014/893212
  79. Haley RW, 1999, TOXICOL APPL PHARM, V157, P227, DOI 10.1006/taap.1999.8703
  80. Hotopf M, 2003, J OCCUP ENVIRON MED, V45, P668, DOI 10.1097/01.jom.0000071506.96740.39
  81. Huang DB, 2018, CANCER CELL INT, V18, DOI 10.1186/s12935-018-0657-1
  82. HUMBERT R, 1993, NAT GENET, V3, P73, DOI 10.1038/ng0193-73
  83. Ikhlef S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173385
  84. Jacob KD, 2013, MECH AGEING DEV, V134, P139, DOI 10.1016/j.mad.2013.02.008
  85. Jalilian Ali, 2008, Arch Iran Med, V11, P544
  86. Jamroz-Wisniewska A, 2017, INT J NEUROSCI, V127, P709, DOI 10.1080/00207454.2016.1241782
  87. Jesko H, 2017, NEUROCHEM RES, V42, P876, DOI 10.1007/s11064-016-2110-y
  88. Johnston-Carey HK, 2016, CRIT REV BIOCHEM MOL, V51, P268, DOI 10.3109/10409238.2016.1172554
  89. Kalia LV, 2015, LANCET, V386, P896, DOI 10.1016/S0140-6736(14)61393-3
  90. Kanasi E, 2016, PERIODONTOL 2000, V72, P13, DOI 10.1111/prd.12126
  91. Karlsson H, 2015, HANDB EXP PHARMACOL, V224, P207, DOI 10.1007/978-3-319-09665-0_5
  92. Kilic U, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117954
  93. Kim EK, 2015, ARCH TOXICOL, V89, P867, DOI 10.1007/s00204-015-1472-2
  94. Kirbas A, 2013, J CLIN NEUROSCI, V20, P1106, DOI 10.1016/j.jocn.2012.09.020
  95. Koren-Gluzer M, 2013, ATHEROSCLEROSIS, V229, P71, DOI 10.1016/j.atherosclerosis.2013.03.028
  96. Kruger M, 2016, ONCOTARGET, V7, P51082, DOI 10.18632/oncotarget.9013
  97. Kruger M, 2015, J CANCER RES CLIN, V141, P1757, DOI 10.1007/s00432-015-1941-2
  98. Kubben N, 2017, NAT REV MOL CELL BIO, V18, P595, DOI 10.1038/nrm.2017.68
  99. Kunutsor SK, 2016, ATHEROSCLEROSIS, V245, P143, DOI 10.1016/j.atherosclerosis.2015.12.021
  100. Lee SJ, 2018, BMB REP, V51, P538, DOI 10.5483/BMBRep.2018.51.10.181
  101. Lee YS, 2012, EXP DERMATOL, V21, P682, DOI 10.1111/j.1600-0625.2012.01555.x
  102. Lescai F, 2009, AGEING RES REV, V8, P277, DOI 10.1016/j.arr.2009.04.001
  103. Lesnefsky EJ, 2003, ARCH BIOCHEM BIOPHYS, V420, P287, DOI 10.1016/j.abb.2003.09.046
  104. Levy D, 2018, BIOCHEM BIOPH RES CO, V505, P1043, DOI 10.1016/j.bbrc.2018.10.008
  105. Levy D, 2017, CHEM PHYS LIPIDS, V207, P223, DOI 10.1016/j.chemphyslip.2017.06.009
  106. Levy E, 2007, AM J PHYSIOL-GASTR L, V293, pG1252, DOI 10.1152/ajpgi.00369.2007
  107. Li XC, 2016, ACS CHEM BIOL, V11, P3122, DOI 10.1021/acschembio.6b00527
  108. Li XT, 2016, J THORAC DIS, V8, P430, DOI 10.21037/jtd.2016.02.26
  109. Li YF, 2016, J COASTAL RES, P22, DOI 10.2112/SI74-003.1
  110. Liguori I, 2018, CLIN INTERV AGING, V13, P757, DOI 10.2147/CIA.S158513
  111. Liu HH, 2015, AGEING RES REV, V19, P43, DOI 10.1016/j.arr.2014.12.001
  112. Liu YF, 2008, FREE RADICAL BIO MED, V45, P743, DOI 10.1016/j.freeradbiomed.2008.05.024
  113. Lou-Bonafonte JM, 2015, NUTRIENTS, V7, P4068, DOI 10.3390/nu7064068
  114. Loued S, 2013, BRIT J NUTR, V110, P1272, DOI 10.1017/S0007114513000482
  115. Mackness B, 2004, BIOCHEM BIOPH RES CO, V318, P680, DOI 10.1016/j.bbrc.2004.04.056
  116. Mackness B, 2003, CIRCULATION, V107, P2775, DOI 10.1161/01.CIR.0000070954.00271.13
  117. Mackness B, 2001, ARTERIOSCL THROM VAS, V21, P1451, DOI 10.1161/hq0901.094247
  118. Mackness B, 2012, PANMINERVA MED, V54, P83
  119. Mackness B, 1997, ARTERIOSCL THROM VAS, V17, P1233, DOI 10.1161/01.ATV.17.7.1233
  120. Mackness B, 1998, FEBS LETT, V423, P57, DOI 10.1016/S0014-5793(98)00064-7
  121. Mackness B, 1997, BRIT J PHARMACOL, V122, P265, DOI 10.1038/sj.bjp.0701390
  122. Mackness B, 1998, GEN PHARMACOL-VASC S, V31, P329, DOI 10.1016/S0306-3623(98)00028-7
  123. Mackness B, 2003, PHARMACOGENETICS, V13, P81, DOI 10.1097/00008571-200302000-00004
  124. Mackness B, 2006, ARTERIOSCL THROM VAS, V26, P1545, DOI 10.1161/01.ATV.0000222924.62641.aa
  125. Mackness B, 2010, ADV EXP MED BIOL, V660, P143, DOI 10.1007/978-1-60761-350-3_13
  126. Mackness M., 2014, HDL HDB BIOL FUNCTIO, P273
  127. MACKNESS MI, 1991, FEBS LETT, V286, P152, DOI 10.1016/0014-5793(91)80962-3
  128. MACKNESS MI, 1989, BIOCHEM PHARMACOL, V38, P385, DOI 10.1016/0006-2952(89)90376-6
  129. MACKNESS MI, 1995, ATHEROSCLEROSIS, V115, P243, DOI 10.1016/0021-9150(94)05524-M
  130. MACKNESS MI, 1993, BIOCHEM J, V294, P829, DOI 10.1042/bj2940829
  131. MACKNESS MI, 1993, ATHEROSCLEROSIS, V104, P129, DOI 10.1016/0021-9150(93)90183-U
  132. Mackness M, 2015, GENE, V567, P12, DOI 10.1016/j.gene.2015.04.088
  133. Marz W, 2017, CLIN RES CARDIOL, V106, P663, DOI 10.1007/s00392-017-1106-1
  134. Mahrooz A, 2018, CLIN CHIM ACTA, V484, P40, DOI 10.1016/j.cca.2018.05.037
  135. Mahrooz A, 2016, CURR CLIN PHARMACOL, V11, P259, DOI 10.2174/1574884711666160915153433
  136. Marchegiani F, 2009, MOL GENET METAB, V98, P314, DOI 10.1016/j.ymgme.2009.05.008
  137. Marsillach J, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-3
  138. Martinez C, 2010, NEUROMOL MED, V12, P217, DOI 10.1007/s12017-009-8095-9
  139. Mau T, 2018, EXP GERONTOL, V105, P27, DOI 10.1016/j.exger.2017.10.014
  140. Mehdi MM, 2012, ARCH MED RES, V43, P438, DOI 10.1016/j.arcmed.2012.08.012
  141. Menini T, 2014, REDOX REP, V19, P49, DOI 10.1179/1351000213Y.0000000071
  142. Mete R, 2013, EUR REV MED PHARMACO, V17, P2884
  143. Mochizuki H, 1998, GENE, V213, P149, DOI 10.1016/S0378-1119(98)00193-0
  144. Moghtaderi A, 2011, CLIN BIOCHEM, V44, P795, DOI 10.1016/j.clinbiochem.2011.04.010
  145. Motti C, 2001, ATHEROSCLEROSIS, V158, P35, DOI 10.1016/S0021-9150(00)00765-6
  146. Moya C, 2018, N-S ARCH PHARMACOL, V391, P349, DOI 10.1007/s00210-018-1473-9
  147. Ng CJ, 2007, ARTERIOSCL THROM VAS, V27, P1368, DOI 10.1161/ATVBAHA.106.134189
  148. Ng CJ, 2006, MOL GENET METAB, V89, P368, DOI 10.1016/j.ymgme.2006.07.004
  149. Ng CJ, 2001, J BIOL CHEM, V276, P44444, DOI 10.1074/jbc.M105660200
  150. Nozue T, 2013, AM J CARDIOVASC DIS, V3, P255
  151. Oglodek EA, 2017, PHARMACOL REP, V69, P837, DOI 10.1016/j.pharep.2017.03.015
  152. Pai SG, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0471-6
  153. Paul KC, 2017, ENVIRON INT, V107, P75, DOI 10.1016/j.envint.2017.06.018
  154. Pera-Kajan J, 2012, AMINO ACIDS, V43, P1405, DOI 10.1007/s00726-012-1321-z
  155. Pinizzotto M, 2001, DIABETOLOGIA, V44, P104, DOI 10.1007/s001250051586
  156. Pirillo A, 2017, ATHEROSCLEROSIS SUPP, V27, pE1, DOI 10.1016/j.atherosclerosissup.2017.05.001
  157. Pradas I, 2019, REDOX BIOL, V21, DOI 10.1016/j.redox.2019.101127
  158. Precourt LP, 2012, AM J PHYSIOL-GASTR L, V303, pG623, DOI 10.1152/ajpgi.00039.2012
  159. PrimoParmo SL, 1996, GENOMICS, V33, P498, DOI 10.1006/geno.1996.0225
  160. Qujeq D, 2018, J RES MED SCI, V23, DOI 10.4103/jrms.JRMS_88_18
  161. Rains JL, 2011, FREE RADICAL BIO MED, V50, P567, DOI 10.1016/j.freeradbiomed.2010.12.006
  162. Rajkovic MG, 2011, BIOCHEM MEDICA, V21, P122
  163. Rea IM, 2004, EXP GERONTOL, V39, P629, DOI 10.1016/j.exger.2003.11.019
  164. Reddy ST, 2001, ARTERIOSCL THROM VAS, V21, P542, DOI 10.1161/01.ATV.21.4.542
  165. Reed TT, 2011, FREE RADICAL BIO MED, V51, P1302, DOI 10.1016/j.freeradbiomed.2011.06.027
  166. Rognoni Andrea, 2015, Cardiovascular & Hematological Agents in Medicinal Chemistry, V13, P10
  167. Rom O, 2016, CHEM-BIOL INTERACT, V259, P394, DOI 10.1016/j.cbi.2016.05.009
  168. Rongo C, 2015, EMBO J, V34, P2310, DOI 10.15252/embj.201592504
  169. Rosa-Fernandes L, 2017, CHEM PHYS LIPIDS, V207, P231, DOI 10.1016/j.chemphyslip.2017.06.008
  170. Rosenblat M, 2006, J BIOL CHEM, V281, P7657, DOI 10.1074/jbc.M512595200
  171. Rosenblat M, 2003, ARTERIOSCL THROM VAS, V23, P468, DOI 10.1161/01.ATV.0000059385.95664.4D
  172. Ruiz JLM, 2013, BIOCHEM PHARMACOL, V86, P80, DOI 10.1016/j.bcp.2013.02.033
  173. Sadowska-Bartosz I, 2014, BIOMED RES INT, DOI 10.1155/2014/404680
  174. Saeidi Mohsen, 2017, Open Biochem J, V11, P47, DOI 10.2174/1874091X01711010047
  175. Salmon AB, 2010, FREE RADICAL BIO MED, V48, P642, DOI 10.1016/j.freeradbiomed.2009.12.015
  176. Sanghera DK, 2008, ANN HUM GENET, V72, P72, DOI 10.1111/j.1469-1809.2007.00400.x
  177. Saruhan E, 2007, ANN NY ACAD SCI, V1100, P218, DOI 10.1196/annals.1395.022
  178. Schweikert EM, 2012, CELL DEATH DIFFER, V19, P1549, DOI 10.1038/cdd.2012.35
  179. Selek S, 2007, CLIN BIOCHEM, V40, P287, DOI 10.1016/j.clinbiochem.2006.10.028
  180. Shakeri R, 2017, CLIN CHIM ACTA, V474, P34, DOI 10.1016/j.cca.2017.08.037
  181. Shakhparonov MI, 2018, ACTA NATURAE, V10, P92
  182. Shi JJ, 2004, MOL BRAIN RES, V120, P201, DOI 10.1016/j.molbrainres.2003.10.018
  183. Shi SJ, 2017, J BIOL CHEM, V292, P15927, DOI 10.1074/jbc.M117.785253
  184. Shih DM, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8010019
  185. Shih DM, 2015, FASEB J, V29, P1185, DOI 10.1096/fj.14-260570
  186. Shui IM, 2016, CANCER-AM CANCER SOC, V122, P2168, DOI 10.1002/cncr.30045
  187. Shunmoogam N, 2018, VASC HEALTH RISK MAN, V14, P137, DOI 10.2147/VHRM.S165173
  188. Silva SF, 2017, J STEROID BIOCHEM, V169, P164, DOI 10.1016/j.jsbmb.2016.04.017
  189. Soran H, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00222
  190. Sorenson RC, 1995, GENOMICS, V30, P431, DOI 10.1006/geno.1995.1261
  191. Squier TC, 2001, EXP GERONTOL, V36, P1539, DOI 10.1016/S0531-5565(01)00139-5
  192. Steinberg D, 2009, J LIPID RES, V50, pS376, DOI 10.1194/jlr.R800087-JLR200
  193. Stipanuk MH, 2004, ANNU REV NUTR, V24, P539, DOI 10.1146/annurev.nutr.24.012003.132418
  194. SUMMERBELL J, 1993, BRIT J CLIN PHARMACO, V36, P399, DOI 10.1111/j.1365-2125.1993.tb00387.x
  195. Tajiri K, 2013, WORLD J GASTROENTERO, V19, P8459, DOI 10.3748/wjg.v19.i46.8459
  196. Takci Z, 2015, J EUR ACAD DERMATOL, V29, P367, DOI 10.1111/jdv.12556
  197. Tanhapour M, 2018, CLIN RHEUMATOL, V37, P971, DOI 10.1007/s10067-017-3859-3
  198. Tindale LC, 2017, ONCOTARGET, V8, P20612, DOI 10.18632/oncotarget.15296
  199. Vamecq J, 2018, OXID MED CELL LONGEV, DOI 10.1155/2018/6986984
  200. van de Ven RAH, 2017, TRENDS MOL MED, V23, P320, DOI 10.1016/j.molmed.2017.02.005
  201. WALKER CH, 1993, CHEM-BIOL INTERACT, V87, P17, DOI 10.1016/0009-2797(93)90021-P
  202. Wang JC, 2012, CIRC RES, V111, P245, DOI 10.1161/CIRCRESAHA.111.261388
  203. Wang YJ, 2019, EUR J MED CHEM, V161, P48, DOI 10.1016/j.ejmech.2018.10.028
  204. Wei M, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aai8700
  205. White CR, 2017, CURR OPIN LIPIDOL, V28, P397, DOI 10.1097/MOL.0000000000000444
  206. White RF, 2016, CORTEX, V74, P449, DOI 10.1016/j.cortex.2015.08.022
  207. Wu JR, 2017, ONCOTARGET, V8, P25362, DOI 10.18632/oncotarget.15911
  208. Yildiz A, 2008, CLIN BIOCHEM, V41, P779, DOI 10.1016/j.clinbiochem.2008.02.010
  209. Yu Z, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1707-0
  210. Zhan T, 2017, ONCOGENE, V36, P1461, DOI 10.1038/onc.2016.304